Heng Yang

834 total citations
16 papers, 389 citations indexed

About

Heng Yang is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Heng Yang has authored 16 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Heng Yang's work include interferon and immune responses (3 papers), Mosquito-borne diseases and control (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Heng Yang is often cited by papers focused on interferon and immune responses (3 papers), Mosquito-borne diseases and control (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Heng Yang collaborates with scholars based in China, United States and Sweden. Heng Yang's co-authors include Yuting Ma, Qingqing Li, Federico Pietrocola, Jonathan M. Pitt, Heng Zhou, Laurence Zitvogel, Guido Kroemer, Takahiro Yamazaki, Genhong Cheng and Shulong Zu and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Immunological Reviews.

In The Last Decade

Heng Yang

16 papers receiving 385 citations

Peers

Heng Yang
Ryan T. Bishop United Kingdom
Robert Valentine United Kingdom
Chengxiang Wu United States
Wietske Pieters Netherlands
Joana Carvalho United Kingdom
Souparno Bhattacharya United States
Benita Wolf Switzerland
Heng Yang
Citations per year, relative to Heng Yang Heng Yang (= 1×) peers Christine Frantz

Countries citing papers authored by Heng Yang

Since Specialization
Citations

This map shows the geographic impact of Heng Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heng Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heng Yang more than expected).

Fields of papers citing papers by Heng Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heng Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heng Yang. The network helps show where Heng Yang may publish in the future.

Co-authorship network of co-authors of Heng Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Heng Yang. A scholar is included among the top collaborators of Heng Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heng Yang. Heng Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
2.
Howard, Frederick M., Nan Chen, Olwen Hahn, et al.. (2024). Evaluation of cyclin-dependent kinase 4/6 inhibitor-induced serum creatinine elevations in patients with hormone receptor positive breast cancer. Journal of Oncology Pharmacy Practice. 3212339017–3212339017. 1 indexed citations
3.
Wang, Jingfeng, Chaohu Pan, Yu Chen, et al.. (2024). Interferon-stimulated gene PVRL4 broadly suppresses viral entry by inhibiting viral-cellular membrane fusion. Cell & Bioscience. 14(1). 23–23. 2 indexed citations
4.
Polley, Eric C., Peter H. O’Donnell, Frederick M. Howard, et al.. (2023). Retrospective evaluation of adjuvant capecitabine dosing patterns in triple negative breast cancer.. Journal of Clinical Oncology. 41(16_suppl). e12515–e12515. 1 indexed citations
5.
Pan, Chaohu, Xiaorong Li, Lili Li, et al.. (2022). Enhancing the HSV-1-mediated antitumor immune response by suppressing Bach1. Cellular and Molecular Immunology. 19(4). 516–526. 9 indexed citations
6.
Li, Lili, Meiling Gao, Peng Jiao, et al.. (2022). Antibody engineering improves neutralization activity against K417 spike mutant SARS-CoV-2 variants. Cell & Bioscience. 12(1). 63–63. 2 indexed citations
8.
Zu, Shulong, Chunfeng Li, Lili Li, et al.. (2022). TRIM22 suppresses Zika virus replication by targeting NS1 and NS3 for proteasomal degradation. Cell & Bioscience. 12(1). 139–139. 20 indexed citations
9.
Zhao, Jin, Ruiting Li, Fengling Feng, et al.. (2021). Modulation of Antiviral Immunity and Therapeutic Efficacy by 25-Hydroxycholesterol in Chronically SIV-Infected, ART-Treated Rhesus Macaques. Virologica Sinica. 36(5). 1197–1209. 6 indexed citations
10.
Li, Lili, Sirui Li, Junxiao Liu, et al.. (2021). ADP-ribosyltransferase PARP11 suppresses Zika virus in synergy with PARP12. Cell & Bioscience. 11(1). 116–116. 18 indexed citations
11.
Zhu, Xingliang, Chunfeng Li, Shulong Zu, et al.. (2018). E90 subunit vaccine protects mice from Zika virus infection and microcephaly. Acta Neuropathologica Communications. 6(1). 77–77. 19 indexed citations
12.
Ma, Yuting, Jonathan M. Pitt, Qingqing Li, & Heng Yang. (2017). The renaissance of anti‐neoplastic immunity from tumor cell demise. Immunological Reviews. 280(1). 194–206. 52 indexed citations
13.
Yang, Heng, Takahiro Yamazaki, Federico Pietrocola, et al.. (2015). STAT3 Inhibition Enhances the Therapeutic Efficacy of Immunogenic Chemotherapy by Stimulating Type 1 Interferon Production by Cancer Cells. Cancer Research. 75(18). 3812–3822. 77 indexed citations
14.
Yang, Heng, Takahiro Yamazaki, Federico Pietrocola, et al.. (2015). Improvement of immunogenic chemotherapy by STAT3 inhibition. OncoImmunology. 5(2). e1078061–e1078061. 14 indexed citations
15.
Yang, Heng, et al.. (2014). Updated Meta-analysis on HER2 Polymorphisms and Risk of Breast Cancer: Evidence from 32 Studies. Asian Pacific Journal of Cancer Prevention. 15(22). 9643–9647. 12 indexed citations
16.
Yang, Heng, et al.. (2001). Contributions in the domain of cancer research: Review¶Negative regulators of cyclin-dependent kinases and their roles in cancers. Cellular and Molecular Life Sciences. 58(12). 1907–1922. 142 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026